Home

ALK Abelló Jext

Jext. Our prescription medicines include treatments for a wide range of allergic conditions. This link will redirect you to the Electronic Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. The eMC contains links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics. Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff. Read more. Post date. 05/05/2021. Three-month interim report (Q1) 2021. Read more. Post date. 04/28/2021. Release date of three-month interim report (Q1) 2021 for ALK and audio cast Until recently, ALK has distributed an in-licensed adrenaline pen. With the launch of Jext®, ALK expects to improve the company s gross margin and substantially improve earnings from the business area within the next few years. This announcement does not change ALK s outlook for the financial year 2011. ALK-Abelló A/S Jens Bager President and CE ALK-Abelló Company Announcement ALK's new and improved adrenaline pen, JEXT®, approved in Europe Summary: The European competent authorities for medicinal products have just approved ALK's new adrenaline pen, JEXT®, for emergency treatment of severe acute allergic reactions Meanwhile, ALK's existing EAI, Jext ®, will remain an important product for the company in Europe. This announcement does not impact ALK's financial guidance for 2019. ALK-Abelló A/S. For further information please contact: ALK: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525. Media: Jeppe Ilkjær, mobile +45.

Welkom bij Jext. Selecteer het deel van de website dat voor jou van toepassing is. Ik ben een beroepsbeoefenaar. Verder >. Ik ben een volwassen patiënt (19+ jaar) Verder >. Ik ben een tiener patiënt (12-18 jaar) Verder >. Ik ben een kind patiënt (7-11 jaar Jext (als waterstoftartraat) ALK-Abelló bv. Toedieningsvorm Injectievloeistof Sterkte 1 mg/ml Verpakkingsvorm auto-injector 0,15 ml, 0,3 ml. Bevat tevens: natriummetabisulfiet. Uitleg symbolen. XGVS: Dit geneesmiddel is niet opgenomen in het. ALK is een op research gebaseerd farmaceutisch bedrijf, dat wereldwijd actief is, vooral op het vlak van diagnose en behandeling van allergie. ALK streeft ernaar de gezondheid en kwaliteit van leven van allergiepatiënten te verbeteren door de best mogelijke producten en diensten aan te bieden Welcome to Jext ®. Welcome to Jext. ®. I am a Healthcare Professional. enter >. I am an Adult Patient (19+ years) enter >. I am a Teen Patient (12-18 years) enter > ALK in het kort. ALK is een op research gebaseerd farmaceutisch bedrijf, dat wereldwijd actief is, vooral op het vlak van diagnose en behandeling van allergie. ALK streeft ernaar de gezondheid en kwaliteit van leven van allergiepatiënten te verbeteren door de best mogelijke producten en diensten aan te bieden. Lees verder

Your Jext ® has an expiry date and may be less effective after that date. You can register with the ALK Expiry Alert service to receive alerts warning you when your Jext ® is due to expire and needs to be replaced by your GP.. We will send through notifications by either SMS or email, or both, notifying you when your Jext ® is due to expire. When your Jext ® expires, visit your GP to. ALK-Abelló Ltd, 1 Manor Park, Manor Farm Road, Reading RG2 0NA CVR no. 63717916 ∙ T +44 118 903 7940 Privacy notice | Cookie notice | Legal disclamer © 2020 ALK.

Jext ALK - U

ALK Allergy solutions for lif

ALK are working closely with the Department of Health and Social Care to find ways to ease the current situation and ensure patients have a functional, in date device. Supplies of 150mcg strength Jext® remain good and are unaffected. If you require any additional information, please make contact on 0118 903 7940 or info@uk.alk-abello.co Download the free Jext ® app, especially designed to support Jext ® patients 24/7. The app has useful features for on-the-go including: an 'in an emergency' guide and help on holiday. Available for iPhone and Android ALK-Abelló A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy.It is one of the world's largest makers of allergy immunotherapy products (also known as 'allergy vaccines') with 81% of its revenue coming. Order Jext. Trainer Pen. Information entered on this website may be used by a third party for the purposes of fulfilling your request for information or materials. ALK-Abelló Ltd will not pass your details to third parties. We will only send you product information and promotional items we think may be of interest Step 1: Hold the Jext ® in the hand that you use to write with, with your thumb closest to the yellow cap. Step 2: Pull off the yellow cap with your other hand. Step 3: Place the black injector tip against the outer thigh, holding the injector at a right angle (approx. 90°) to the thigh. Step 4: Push the black tip as hard as you can into your outer thigh until you hear a 'click' which.

I listen med links ovenfor findes en oversigt over ALK´s lægemidler inden for allergi. Disse er linket til siden indlaegssedler.dk , hvor du kan søge mere information om lægemidlerne. Sidst opdateret: 2021.02.0

Jext ® is the medicine your child has been given by your doctor to help treat their anaphylaxis.. Jext ® contains a liquid, which works quickly while you wait for the ambulance. This liquid is a medicine called adrenaline. Jext ® automatically injects the adrenaline into their body

ALK launches new, improved adrenaline pen, Jext® in Europ

  1. ALK-Abelló Arzneimittel GmbH. Griegstr. 75 | Haus 25 | D-22763 Hamburg | HRB 126385 | Tel. 040-703845-. Rechtliche Hinweise ∙ Impressum ∙ Datenschutzerklärung
  2. Jext bevat een steriele adrenalineoplossing in een auto-injector om in een noodsituatie een injectie met een enkelvoudige dosis adrenaline aan de zijkant van de dijbeenspier (intramusculaire injectie) te geven. ALK-Abelló A/S Boge Allé 6-8 DK-2970 HORSHOLM (DENEMARKEN) Niet beschikbaa
  3. Jext - ALK-Abelló. Visit Jext - ALK-Abelló website. Adult demonstration video. Child demonstration video. Read Previous HayMax HayMax. Read Next NAROO NAROO. Browse all. Our Partners Our Partners. Live chat. Press Office; Vacancies; Newsletter; Opt-In; Allergy UK on Facebook; Allergy UK on Twitter; Allergy UK on YouTube
  4. Jext is een oplossing voor injectie in een voorgevulde pen. De pen bevat een heldere en kleurloze oplossing in een glazen patroon met latexvrije rubber afsluitingen. Verpakkingsgrootte: 1 voorgevulde pen. 1311-v1-nl-mrt2013. Houder van de vergunning voor het in de handel brengen en fabrikant. ALK-Abelló A/S Bøge Allé 6-8 DK-2970 Hørsholm.
  5. ALK-Abelló A/S, Bøge Allé 6-8, DK-2970 Hørsholm, Denemarken. Registratiehouder / ompakker. Medcor Pharmaceuticals B.V., Ketelmeerstraat 140-144, 8226 JX Lelystad. In het register ingeschreven onder. Jext 300 microgram, oplossing voor injectie in voorgevulde pen. RVG 112245 // 106309 L.v.h.: Oostenrijk. Deze bijsluiter is goedgekeurd in.

ALK-Abelló on 18 and 30 November 2010 to provide pharmacists and senior clinicians in hospital and primary care organisations with the necessary information to facilitate formulary applications for Jext. Therefore ALK-Abelló denied the alleged breach of Clause 3.1 as Jext had been granted a marketing authorization before it started an Die ALK-Abelló Arzneimittel GmbH ist die deutsche Tochter der ALK-Abelló in Dänemark und beschäftigt in Deutschland rund 140 motivierte Mitarbeiter im Innen- und Außendienst. Unsere Mitarbeiter arbeiten täglich daran, unseren Kunden nicht nur die besten Produkte, sondern auch den bestmöglichen Service zu liefern Manager, QA Release, ALK-Abelló A/S Employee-elected. Competences Expertise in production and release of ALK's active pharmaceutical ingredients for SLIT products. Director Since: 2019 Johan Smedsrud Board member . Birth Date: 1972 Maintenance Supporter, Process. ALK-Abelló A/S Jens Bager President and CEO Contact: Jens Bager, JEXT® has been developed by ALK and is eventually expected to be launched worldwide. Until 31 December 2010,. Act quickly if anaphylaxis starts! fdzbfdz. Jext ®. ALK-Abelló Lt

ALK's new and improved adrenaline pen, JEXT®, approved in

ALK-Abelló A/S. Jext 300 micrograms solution for injection in prefilled pen - PL 10085/0053. Jext 150 micrograms solution for injection in prefilled pen - PL 10085/0052 (Adrenaline Tartrate Alk-Abelló BV . Bezoekadres. Transistorstraat. 23-25, 1322CK. Grazax. Grazax bestelformulier. Jext. Pharmalgen bestelformulier. Pharmalgen website. SLITone Ultra Verzoek tot levering en bereiding. SLITone verzoek tot levering en bereiding. Vergoeding ALK immunotherapie. Vermelding in de bedrijvengids. Staat uw bedrijf niet in deze handige.

Corporate governance. ALK has a two-tier management structure consisting of the Board of Directors and the Board of Management. The two boards are independent of each other. The Board of Directors defines the strategic framework for ALK's action plans and activities on the basis of objectives, strategies and policies ALK-Abelló Nordic A/S Bøge Allé 6-8 Bygn. 10 2970 Hørsholm. E-mail: infodk@alk.net T: +45 3816 7070 F: +45 3816 709

ALK announces new epinephrine auto-injector strategy based

  1. 1 Manor Park, Manor Farm Road, Reading, Berkshire, RG2 0NA, UK. Fax. +44 (0)118 903 794
  2. istration of adrenaline to treat anaphylaxis. The Jext website was designed to be a resource for patients prescribed Jext with a separate section for health professionals treating patients with severe allergy
  3. ALK will publish its Q4 performance in connection with the Annual Report on 7 February 2019. ALK-Abelló A/S. For further information please contact: Carsten Hellmann, President & CEO, tel. +45 4574 7576. Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525. Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 201
  4. * ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom
  5. Jext 150 micrograms: One pre-filled pen delivers one dose of 0.15ml solution for injection containing 150 micrograms of adrenaline (as tartrate). 1 ml solution contains 1mg adrenaline (as tartrate). Excipients with known effect: Sodium metabisulphite (E223) and sodium chloride. Jext contains less than 1 mmol sodium (23 mg) per dose

Welkom bij Jex

ALK-Abelló for its adrenaline auto-injector Jext which was indicated for the emergency treatment of severe acute allergic reactions as well as idiopathic or exercise induced anaphylaxis. Meda alleged that two diagrams, entitled 'Jext is designed to be easy to use', failed to accurately reflect the instructions for use in the marketin Today, ALK's (ALKB:DC / OMX: ALK B / AKABY / AKBLF) Board of Directors has considered and approved the 2018 annual report with the following highlights:2018 saw strong progress for ALK's new strategy, keeping ALK on track to deliver accelerated growth of 10% in 2019 with growth across all sales regions and with SLIT-tablets as the key driver Jext as, in ALK-Abelló's view, the majority of the booklet compared EpiPen to Jext. This was not so. Sections 1-7 either discussed auto injectors in very general terms or identified all three available auto injectors without attaching disproportionate weight to any one, including Jext

ALK Abello: ALK releases its driven by continued strong growth from SLIT-tablets and the Jext mobile +45 3050 2014 This information is information that ALK-Abelló A/S is obliged to make. ALK-Abelló Company Announcement ALK and bioCSL enter into a partnership for allergy. Copenhagen, 2015-02-09 09:00 CET -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) and bioCSL announce a partnership in Australia and New Zealand which grants bioCSL exclusive rights to promote and sell ALK's SLIT-tablets against house dust mite and grass pollen allergy, and ALK's Jext ® adrenaline auto. Fra og med juni 2016 er Lundbeckfonden ALK's største og bestemmende aktionær med 67 % af stemmerne (40 % af kapitalen). Læs mere om ALK's ejere Sidst opdateret: 2017.04.1 JEXT ® Therapieportfolio Global Brand Manager for our Venom portfolio and our emergency product for severe allergic reactions. I have been with ALK since 2009 and recently, I embarked on a new exciting adventure, ALK-Abelló Arzneimittel GmbH | Griegstr. 75, Haus 25, D-22763 Hamburg. ALK-Abelló has around 2 million customers worldwide. Key Principal. Carsten Hellmann See more contacts. Industry. Pharmaceutical Manufacturing Manufacturing Sector Pharmaceutical preparations Chemical preparations, nec. Incorporated. 2007. For additional insights sign up for a D&B Hoovers free trial. Website. www.alk.net

adrenaline - Farmacotherapeutisch Kompa

Jext er en auto indsprøjtningen, der anvendes til behandling af anafylaksi, fremstillet af danske ALK-Abelló. Det indeholder adrenalin og injiceres i lårmusklen. Vi tilbyder Jext gennem vores sikre online apotekstjeneste. Adgang til den rette behandling er essentiel, skulle det uventede ske Jext 150 mikrogram Injektionsvæske, opløsning i fyldt pen ALK-Abelló S.A., Miguel Fleta 19, 28037 Madrid, Spanien. ALK JEXT Adrenalin Autoinjektor (Foto: ALK-Abelló) Wien (ots) - Allergikern steht ein neuer Adrenalin-Autoinjektor zur Verfügung: Der moderne Pen wurde von österreichischen Ingenieuren entwickelt und punktet durch eine verlängerte Haltbarkeit, die einfache Handhabung, einer erhöhten Sicherheit durch den integrierten Nadelschutz sowie durch eine verbesserte Temperatur- und Lichtstabilität. ALK-Abelló A / S ( Nasdaq Kopenhagen : ALK B ), ook algemeen bekend als ALK, is een in Denemarken gevestigd farmaceutisch bedrijf dat gespecialiseerd is in de ontwikkeling en productie van producten voor allergie-immunotherapie (AIT) voor de preventie en behandeling van allergie .Het is een van 's werelds grootste producenten van allergie-immunotherapieproducten (ook bekend als. ALK-Abelló A/S. Bøge Allé 6-8. 2970 Hørsholm. Tanska. Valmistaja. ALK-Abelló S.A. Miguel Fleta 19. 28037 Madrid. Espanja. Edustaja. ALK-Abelló Nordic A/S, sivuliike Suomessa. puh. 09 5842 2120. s-posti: infofi@alk.net. Tällä lääkevalmisteella on myyntilupa seuraavissa Euroopan talousalueeseen kuuluvissa jäsenvaltioissa.

Jext ® Soluprick SQ® ALK-Abelló Nordic A/S ∙ Branch office Finland ∙ Linnoitustie 4 ∙ 02600 Espoo ∙ Suomi ∙ T: ( +358) 9 5842 2120 ∙ Tietosuojamenettely | Evästekäytänt. ALK will continue to invest significantly in the strategic transformation of the company in Q4. Free cash flow is now expected at minus DKK 500 million or better (previously: minus DKK 550 million or better). Hørsholm, 9 November 2018. ALK-Abelló A/S. Comparative figures for 2017 are shown in brackets ALK-Abelló A/S Jext 300 micrograms solution for injection in pre-filled pen Jext 150 micrograms solution for injection in pre-filled pen PL 10085/0053 PL 10085/0052 (Adrenaline Tartrate) ALK-Abelló Ltd is recalling the batches listed in the tables on page 2 to patient level Jext on esitäytetty kynä jota käytetään anafylaktisen sokin hoitoon. Tuotteen valmistaja on ALK-Abelló. Valmiste sisältää adrenaliinia ja se pistetään reiden ulkosivuun (pistos lihakseen). Tarjoamme Jext -valmistetta yksityiskäyttöön verkkoapteekkimme kautta. +300 Trustpilot arvostelua. Tilaa nyt ja saat sen keskiviikko 23.

ALK Wereldmarktleider op het gebied van allergie

ALK-Abelló A/S - Bøge Allé 6-8 - DK-2970 Hørsholm - Denmark - www.alk-abello.com Tel +45 4574 7576 - Fax +45 4574 8607 - CVR No 63 71 79 16 To NASDAQ OMX Copenhagen A/S Translation Company release No 21/2010 Hørsholm 13 October 2010 ALK's new and improved adrenaline pen, JEXT®, approved in Europ ALK-Abelló A/S (company registration (CVR) no. 63 71 79 16) (the Company ALK) was held at the Company's registered office, Bøge Allé 1, 2970 Hørsholm, Denmark. The Chairman of the Board of Directors, Steen Riisgaard, welcomed everyone to the Annual Genera

Welcome to Jex

Indtil for nylig har ALK distribueret en indlicenseret adrenalinpen. Med. lanceringen af Jext® forventer ALK at forbedre selskabets bruttomargin og inden. for få år at øge indtjeningen fra forretningsområdet væsentligt. Denne meddelelse ændrer ikke ved ALKs forventninger til regnskabsåret 2011. ALK-Abelló A/S. Jens Bager. Adm. direktø ‎Download the free Jext® app, especially designed to support Jext® patients 24/7. The app has useful features for on-the-go including: an 'in an emergency' guide and help on holiday. 'IN AN EMERGENCY' GUIDE • Step-by-step audio and visual instructions for using Jext® in an emergency. • The app pr ALK-Abelló A/S - Bøge Allé 6-8 - DK-2970 Hørsholm - Denmark - www.alk.net Tel +45 4574 7576 - Fax +45 4574 8607 - CVR No 63 71 79 16 Revenue by geographies Europe Q2 revenue in Europe declined by 3% to DKK 414 million (430). Hence, Europe accounted for 67% of Group revenue (81%). The decline was mainly due to the Jext® adrenalin ALK-Abelló A/S - Bøge Allé 6-8 - DK-2970 Hørsholm - Denmark - www.alk.net Tel +45 4574 7576 - Fax +45 4574 8607 - CVR No 63 71 79 16 to be influenced by changes in reimbursement schemes. ALK started to benefit from the Simplify initiatives introduced in late 2012 to drive efficiency improvements and eventually reduce capacity costs

ALK BENELUX A world leader in allergy immunotherap

ALK-Abelló A/S - Bøge Allé 6-8 - DK-2970 Hørsholm - Denmark - www.alk.net Tel +45 4574 7576 - Fax +45 4574 8607 - CVR No 63 71 79 16 Throughout 2013, sales of Jext® adrenaline auto-injectors have performed as expected. Although still influenced by changes in reimbursement schemes and difficult market conditions, European vaccin ALK-Abelló Ltd is recalling the above batches of Jext 300 and 150 micrograms solution for injection in pre-filled pens to patient level. This is because a potential problem with delivery of the dosage following activation of the auto injector has been identified The detailed response from ALK-Abello is given below. The Panel noted that Jext received a marketing authorization on 12 November 2010. The formulary pack and template were distributed for use on 18 and 30 November. The promotion of Jext was after receipt of its marketing authorization and thus no breach of the Code was ruled

Kontakt | JextComprar Jext Online - Farmacia Registrada - Treated

Jext es una pluma precargada para tratar la anafilaxia, fabricado por ALK-Abelló. Para comprar Jext complete nuestro cuestionario de salud. Un médico colegiado revisará sus respuestas y su tratamiento será enviado en solo un día laborable. Nuestra Calificación en Truspilot es de excelente con un 9,2 sobre 1 ALK-Abelló A/S has applied for a marketing authorisation for Jext, solution for injection in pre-filled pen, 150 microgram, and 300 microgram. The active substance is Adrenaline tartrate. For approved indications, see the Summary of Product Characteristics. II. QUALITY ASPECTS II.1 Introductio Please check your Jext now! The new Jext auto injector Important safety information for patients using Jext® solution for injection in pre-filled pen.. Routine testing conducted by ALK-Abelló has revealed that during the production process in some batches the needle may have become bent, causing the needle to curl up inside the injector housing upon activation and consequently causing the. ALK-Abelló A/S - Bøge Allé 6-8 - DK-2970 Hørsholm - Denmark - www.alk.net Tel +45 4574 7576 - CVR No 63 71 79 16 - LEI code: 529900SGCREUZCZ7P020 Page 1 of 2 UK authority extends use of specific batches of Jext® as adrenaline pen shortage continue 1050762_Pil_UK_Jet_draft130319_JEXT 19-03-2013 15:26 Side 1. The inspection window in the label is filled by a coloured plastic rod (white in Jext300 and blue in Jext150) to confirm that the auto-injector has activated and the adrenaline ALK-Abelló A/S, Bøge Allé 6-8

Jext® Adult

Jext 150 microgram injecteert één enkelvoudige dosis van 150 microgram adrenaline in 0,15 ml oplossing voor injectie. Jext 300 injecteert één enkelvoudige dosis van 300 microgram adrenaline in 0,3 ml oplossing voor injectie. De andere stoffen in dit middel zijn: natriumchloride, natriummetabisulfiet (E223), zoutzuur, water voor injectie Jext® has been designed to be simple and reliable. Jext® comes in two different doses. 300 micrograms for patients weighing greater than 30kg, and 150 micrograms for patients weighing between 15 - 30 kg. Each Jext injects a premeasured single dose of adrenaline for the emergency treatment of anaphylaxis ALK Abelló BV Postbus 60022 1320 AA Almere Tel. 036-5397840 Email: infonl@alk.net. 4.2. Via de site verstrekte informatie, en die niet direct of indirect tot u herleidbaar is, zal niet als vertrouwelijk worden aangemerkt

ALK-ABELLÓ A/S : Nieuws en informatie aandeel ALK-ABELLÓ A/S | ALK B | Nasdaq Copenhage Frankrijk ALK-Abelló A/S Boge Allé 6-8. 2970 Horsholm Denmark . Adrenaline JEXT 150 microgrammes, solution for injection in pre-filled pen 150 µg Oplossing voor injectie in een voorgevulde pen Intramusculair gebruik Frankrijk ALK-Abelló A/S Boge Allé 6-8. 2970 Horsholm Denmar Jext ® stehna, kým u pevne zatláčajte do ť r e Jext e ® 1 2 2 10 SEK. IHLY ALK-Abelló A/S Bøge Allé 6-8, DK-2970 Hørsholm ALK-ABELLÓ Madrid Vare nr.: Jext Trainer Dato: 21.12.2015 Label: 64 x 105,5 mm Korrektur nr.: 0. Sort Cyan Magenta Digital Printing Gul Gray 4 Manuell Stan Reviews van ALK-Abelló medewerkers over de bedrijfscultuur, salarissen, secundaire arbeidsvoorwaarden, werkdruk, het management, doorgroeimogelijkheden en meer bij ALK-Abelló ALK Norway: ALK-Abelló Nordic, Filial av utlandsk aksjeselskap, Lensmannslia 4, 1386 Asker, Tel +47 99 44 60 40, epost infono@alk.net. ALK Finland: ALK-Abelló Nordic A/S, Branch office in Finland, Mannerheimintie 113, 00280 Helsinki, epost infofi@alk.net . The contact details of ALK Data Protection Officer(s), are available here

Products ALK - U

ALK Abelló A/S Denmark RMS Sweden Date of last change 29.04.2021 ATC-Code C01CA24 Epinephrine: CMS Country Jext . MR Number: SE/H/0908/001 Date of outcome: 12.10.2010 Type of application Level 1: Level 2: Level 3: Level 4: Level 5: Known Active. PRODUKTKATALOG ALK-Abelló Nordic, Filial av utenlandsk aksjeselskap Oppdatert 04.06.2020 Lensmannslia 4 1386 Asker R - Registrert legemiddel Tel: 99 44 60 40 L - Legemiddel på lisens HUDPRIKKTEST NOK (pris, AUP) LANSETTER 1046488 ALK Lancet 1 200 st CE SOLUPRICK SQ / SOLUPRICK KONTROLLER 02 46 81 Positiv kontroll 1 10 mg/ml 2 ml R 138,6 ALK-Abelló is producent van o.a. GRAZAX®, Oralgen® en Alutard SQ®. ALK-Abelló streeft ernaar de gezondheid en kwaliteit van leven van allergiepatiënten te verbeteren door de best mogelijke producten en diensten aan te bieden. Het volledige assortiment van ALK bestaat uit: Sublinguale immunotherapie GRAZAX®, allergie immunotherapie table ALK-Abello Ltd, UK ALK-Abelló A/S , also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products (also known as 'allergy vaccines')Pharma Solution is the [

Current Corporate Partners | Work with Us | Allergy UKAlk-Abelló fabricará en España el autoinyector de adrenalinaJext adrenalin | iPhone/iPad | Danske AppsDownloads Patientenbroschüren | ALK Österreich - Für ein Leben ohne Allergie

Primary contact details for ALK's headquarter in Hørsholm are: ALK-Abelló A/S ∙ Bøge Allé 6-8 (Visiting Address: Bøge Allé 1) ∙ DK-2970 Hørsholm ∙ Denmark ∙ T +45 45 74 75 76 ∙ email reception@alk-abello.com. The contact details of the ALK Data Protection Officer are available here Jext ® GeheugensTeuntjes ALK Abelló BV ∙ Transistorstraat 25 ∙ 1322 CK Almere ∙ Nederland ∙ T +31 36 539 78 40 ∙ email infonl@alk.net. De contactgegevens van de functionaris(sen) gegevensbescherming van ALK zijn hier te vinden. DOOR ONS VERWERKTE PERSOONSGEGEVENS ALK-Abelló BV Transistorstraat 25 1322 CK Almere (Flevoland) (Nederland) (+31) 36 53 97 840 infonl@alk Jext® Adrenaline auto-injector is bedoeld voor iedereen in een allergische noodsituatie en verkrijgbaar in 150 en 300 microgram. Bedrijf in Almere, Flevoland Michael Bras National Account Manager BENELUX bij ALK Abelló (Sales Manager Belgium a.i.) Lelystad, Flevoland, Nederland Meer dan 500 connectie ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Jeppe Ilkjær, mobile +45 3050 2014 Audio castToday, ALK. Prantsusmaa ALK-Abelló A/S Boge Allé 6-8. 2970 Horsholm Denmark . Adrenaline JEXT 150 microgrammes, solution for injection in pre-filled pen 150 µg Süstelahus pen-süstlis Intramuskulaarne Prantsusmaa ALK-Abelló A/S Boge Allé 6-8. 2970 Horsholm Denmar